Stockscreener 앱 받기
2.34
15.84%
0.32
시간 외 거래:
2.25
-0.09
-3.85%
전일 마감가:
$2.02
열려 있는:
$2.02
하루 거래량:
546.65K
Relative Volume:
1.48
시가총액:
$123.34M
수익:
$1.82M
순이익/손실:
$-267.63M
주가수익비율:
-0.116
EPS:
-20.1639
순현금흐름:
$-50.53M
1주 성능:
+38.46%
1개월 성능:
+42.68%
6개월 성능:
+50.97%
1년 성능:
-21.48%
1일 변동 폭
$1.9749
$2.415
1주일 범위
$1.6469
$2.415
52주 변동 폭
$1.09
$3.40
Cibus Inc Stock (CBUS) Company Profile
명칭
Cibus Inc
전화
(858) 450-0008
주소
6455 NANCY RIDGE DRIVE, SAN DIEGO
CBUS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.34 | 106.47M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-29 | 개시 | Alliance Global Partners | Buy |
| 2024-07-19 | 재개 | Canaccord Genuity | Buy |
| 2023-10-09 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 재개 | Canaccord Genuity | Buy |
Cibus Inc 주식(CBUS)의 최신 뉴스
Cibus repurchases shares from employee in board-approved transaction By Investing.com - Investing.com Australia
Cibus repurchases shares from employee in board-approved transaction - Investing.com
Cibus executes minor internal Class A share repurchase - TipRanks
Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America - AgriBusiness Global
Retail Trends: Why Cibus Inc stock is a must watch in 2025Weekly Market Outlook & Daily Profit Maximizing Tips - moha.gov.vn
Cibus and Interoc sign LOI for herbicide-tolerant rice in Latin America By Investing.com - Investing.com South Africa
Cibus, Inc. (NASDAQ:CBUS) surges 15%; individual investors who own 43% shares profited along with insiders - Yahoo Finance
Cibus (CBUS) and Interoc Plan Commercialization of Herbicide-Tol - GuruFocus
Cibus and Interoc sign LOI for herbicide-tolerant rice in Latin America - Investing.com India
Cibus and Interoc Advance Rice Commercialization Strategy - GlobeNewswire
Retail investors invested in Cibus, Inc. (NASDAQ:CBUS) up 11% last week, insiders too were rewarded - simplywall.st
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), UCB SA (GB:0NZT) and Cibus (CBUS) - The Globe and Mail
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Short Interest in Cibus, Inc. (NASDAQ:CBUS) Decreases By 32.9% - MarketBeat
Stock Market Recap: Why Cibus Inc stock is a must watch in 20252025 Volatility Report & Verified Short-Term Plans - moha.gov.vn
Aug Ideas: Is Cibus Inc. stock attractive for long term wealth buildingJuly 2025 Spike Watch & Low Volatility Stock Suggestions - Улправда
Will Cibus Inc. stock pay special dividendsWeekly Profit Summary & Long-Term Capital Growth Ideas - Улправда
Cibus (CBUS) EV-to-OCF : -1.87 (As of Dec. 19, 2025) - GuruFocus
How Cibus Inc. stock responds to policy changesJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - Улправда
Craig Wichner Net Worth (2025) - GuruFocus
Will Cibus Inc. stock attract more institutional investorsEarnings Beat & Short-Term Trading Alerts - bolumsonucanavari.com
Guidance Update: Is Cibus Inc. stock recession proof2025 Trade Ideas & High Conviction Buy Zone Picks - Улправда
Is Cibus Inc. stock recession proof2025 Bull vs Bear & Weekly Market Pulse Alerts - Улправда
Gratia Capital LLC Acquires New Shares in Cibus, Inc. $CBUS - MarketBeat
Cibus director Prante sells $2,875 in stock - MSN
Signal Recap: Can Cibus Inc stock maintain growth trajectory2025 Macro Impact & Weekly Return Optimization Alerts - moha.gov.vn
CBUS FinancialsIncome Statement - Quiver Quantitative
Cibus (CBUS) Applauds EU Agreement on Gene-Edited Plant Regulati - GuruFocus
Cibus Welcomes EU Political Agreement on New Genomic Techniques, Supporting Advances in Plant Breeding Innovation - Quiver Quantitative
Cibus (Nasdaq: CBUS) sees EU NGT agreement advancing gene-edited plant rules - Stock Titan
Canaccord Genuity Remains a Buy on Cibus (CBUS) - The Globe and Mail
Cibus’ (CBUS) “Buy” Rating Reaffirmed at Canaccord Genuity Group - Defense World
Is Cibus Stock Built to Withstand a Pullback? - Trefis
Canaccord Genuity Maintains Cibus (CBUS) Buy Recommendation - Nasdaq
Cibus (CBUS) Stock Rating Maintained at "Buy" by Canaccord Genui - GuruFocus
Cibus (NASDAQ:CBUS) Earns "Buy" Rating from Canaccord Genuity Group - MarketBeat
ETFs Investing in Cibus, Inc. Stocks - TradingView — Track All Markets
What drives Cibus Inc stock priceStock Valuation Metrics & Free High Frequency Trading Ideas - earlytimes.in
Cibus (CBUS) Total Equity : $52.03 Mil (As of Sep. 2025) - GuruFocus
Cibus (NASDAQ:CBUS) and Brasilagro Cia Brasileira De Propriedades Agricolas (NYSE:LND) Critical Review - Defense World
Insider Sell: How Cibus Inc. stock responds to policy changesJuly 2025 Sector Moves & Precise Trade Entry Recommendations - moha.gov.vn
Cibus director Gerhard Prante sells $2,817 in stock - MSN
Cibus CBUS grants director 45,627 options expiring in 2035 - Stock Titan
[Form 3] Cibus, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Cibus (CBUS) Other Stockholders Equity : $0.00 Mil (As of Sep. 2025) - GuruFocus
Cibus, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
What is the fair value of Cibus Inc. stock nowMarket Risk Report & Reliable Trade Execution Plans - newser.com
Is Cibus Inc. stock overvalued by current metricsPrice Action & AI Driven Stock Movement Reports - newser.com
Sidoti Csr Weighs in on Cibus' FY2025 Earnings (NASDAQ:CBUS) - MarketBeat
Cibus (CBUS) EBIT per Share : $-2.55 (TTM As of Sep. 2025) - GuruFocus
Will Cibus Inc. stock continue upward momentumWeekly Profit Report & Fast Gaining Stock Reports - newser.com
Cibus Inc (CBUS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):